Corcept Therapeutics
CORT
$25.13
Share price
0.28%
Change (1 day)
12.24%
Change (1 year)
Categories
Corcept Therapeutics (CORT) - Total debt
Total debt on the balance sheet as of December 2023 : $0.15 M
According to Corcept Therapeutics 's latest financial reports the company's total debt is $0.15 M. A company’s total debt is the sum of all current and non-current debts.
Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.15 M | -86.79% |
| 2022-12-31 | $1.14 M | 117.3% |
| 2021-12-31 | $0.52 M | -79.38% |
| 2020-12-31 | $2.55 M | -26.29% |
| 2019-12-31 | $3.46 M | |
| 2018-12-31 | $N/A | |
| 2016-12-31 | $14.66 M | -2.01% |
| 2015-12-31 | $14.96 M | 58.8% |
| 2014-12-31 | $9.42 M | 64.1% |
| 2013-12-31 | $5.74 M | 116.72% |
| 2012-12-31 | $2.65 M | |
| 2010-12-31 | $N/A | -100% |
| 2009-12-31 | $0 M | -62.5% |
| 2008-12-31 | $0.01 M | -44.83% |
| 2007-12-31 | $0.02 M | -30.95% |
| 2006-12-31 | $0.04 M | -22.22% |
| 2005-12-31 | $0.05 M | |
| 2003-12-31 | $0.52 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $29.33 B | 19,425,065.56% | 🇺🇸 USA |
 Novartis NVS | $27.28 B | 18,068,774.17% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 46,917,118.54% | 🇺🇸 USA |
 Eli Lilly LLY | $25.22 B | 16,705,396.69% | 🇺🇸 USA |
 Merck MRK | $35.05 B | 23,215,131.79% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 38,019,105.30% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.27 B | 180,445.70% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.26 B | 176,170.86% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.09 B | 725,562.25% | 🇺🇸 USA |